Exercise 18-7 Buffalo Biotech enters into a licensing agreement with Pang Pharmaceutical for a drug under development. Buffalo will receive a payment of $10,900,000 if the drug receives regulatory approval. Based on prior experience in the drug-approval process, Buffalo determines it is 75% likely that the drug will gain approval and a 25% chance of denial. Determine the transaction price of the arrangement for Buffalo Biotech. Transaction price s SHOW LIST OF ACCOUNTS LINK TO TEXT Assuming that regulatory approval was granted on December 20, 2017, and that Buffalo received the payment from Pang on January 15, 2018, prepare the journal entries for Buffalo The license meets the criteria for point-in-time revenue recognition. (Credit account titles are automatically indented when the amount is entered. Do not indent manually. If no entry is required, select "No entry" for the account titles and enter 0 for the amounts.) Account Titles and Explanation Debit Credit